Clinical Trial: Scotoma Reduction in AMD Patients Treated With Ranibizumab

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase I/II Study to Evaluate Scotoma Reduction in And Limited Visual Acuity in aGe Related Macular Degeneration Patients Treated With Intravitreal Lucentis

Brief Summary: This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.

Detailed Summary: Patients with severe wet macular degeneration and scarring in the center of the retina may benefit from treatment if the size of the blind spot is reduced wiht injections of Lucentis.
Sponsor: Retina Research Foundation

Current Primary Outcome: scotoma reduction [ Time Frame: 12 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: improved visual function [ Time Frame: 12 months ]

Original Secondary Outcome: Same as current

Information By: Retina Research Foundation

Dates:
Date Received: April 29, 2007
Date Started: March 2007
Date Completion:
Last Updated: July 28, 2011
Last Verified: July 2011